- India’s biopharma sector, contributing 49% to biotechnology output, drives global health innovation.
- The Biologics CDMO market is projected to grow at a 12.78% CAGR, reaching $24.77 billion by 2028, with Indian companies investing 8-10% in R&D.
- India, the second-largest vaccine producer globally, manufactures 14.5 million kg annually, reflecting its critical role in healthcare.
To know more Click
Expert Consulting Assistance for Indian Bioenergy & Biomaterials
Talk to BioBiz
Call Muthu – 9952910083
Email – ask@biobiz.in
